Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals

The auto industry is pulling back on its 'capital junkie' tendencies after unprecedented spending on EVs, self-driving

The auto industry has an addiction.

Pakistan ends lockdown of its capital after Imran Khan supporters are dispersed by police

Authorities have reopened roads linking Pakistan’s capital with the rest of the country, ending a four-day lockdown, after using tear gas and firing into the air to disperse supporters of ...

World - ABC News - 14 hours ago

Cargo ship launched to space station with science gear, holiday treats

With an Election Day docking, the cargo ship will deliver 3 tons of supplies and equipment, including an unusual wooden satellite.

Reasons to be hopeful: five ways science is making the world better

If Trump’s re-election is getting you down, these innovations in medicine and technology should cheer you up. Ian Sample Continue reading...

World - The Guardian - November 9

Why do we cry? An expert explains the science behind it.

Why do we cry? There's actually some good reasons for it — and an explanation for why shedding some tears can make us feel better.

Junk science provides legal ammo for mass lawsuit deception

Plaintiffs' lawyers are using junk science to manipulate mass tort cases, causing a chilling effect on scientific innovation and a hidden "tort tax" of $3,965 per family.

Politics - The Hill - November 16

Bestselling author explains the science of happiness: "You can do the work"

Bestselling author and Harvard professor Arthur Brooks opens up about how enjoyment, satisfaction and meaning in life can increase a person's wellbeing.

'It's not rocket science': Senate Democrats detail lessons from their victories

Senate Democrats who pulled off victories even as President-elect Donald Trump won their states believe the Democratic Party can learn some lessons from their races as it grapples with losing ...

Politics - NBC News - November 19

Weed for PTSD? Eager for Better Cannabis Science, F.D.A. Clears Study.

The decision is the latest sign that federal health officials want more research on medical marijuana as its use grows.

Top stories - The New York Times - November 20

CAI advances readiness and excellence in life sciences and mission-critical fields.

Amid rapid tech advancements and strict regulations, CAI empowers partners with innovative tools and methods to ensure flexibility, speed, and scalability in life sciences and mission-critical ...

‘The science of fluoride is starting to evolve’: behind the risks and benefits of the mineral

With RFK Jr and a court ruling, conversation on fluoride, in about 72% of US community water supplies, has exploded. A national conversation about fluoride’s health benefits exploded this fall ...

World - The Guardian - 10 hours ago

Royal Caribbean CEO: Americans are ‘wealthier than ever’ and love to travel

Royal Caribbean’s stock pulls back from a record after revenue, profit outlook for the current quarter disappoint.

Business - MarketWatch - October 29

SoFi’s stock rally takes a breather despite improving credit trends

Analysts called out improvement in credit performance as a major positive coming out of SoFi’s third-quarter report, but the stock was falling hard.

Business - MarketWatch - October 29

Trump's social media company is now worth more than Musk's X after recent surge in stock price

Donald Trump’s Truth Social is now worth more than Elon Musk’s X

Tech - ABC News - October 29

Reddit’s stock soars after social-media platform turns a profit, beats Q3 sales and earnings estimates

Reddit said Tuesday that it turned a profit in its third quarter — a first for the social-media platform since becoming a public company earlier this year.

Business - MarketWatch - October 30

Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.

Business - CNBC - October 30

Latest in Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals